Cargando…
Therapeutic effect of hepatocyte growth factor-secreting mesenchymal stem cells in a rat model of liver fibrosis
Bone marrow-derived mesenchymal stromal cells (MSCs) have been reported to be beneficial for the treatment of liver fibrosis. Here, we investigated the use of genetically engineered MSCs that overexpress hepatocyte growth factor (HGF) as a means to improve their therapeutic effect in liver fibrosis....
Autores principales: | Kim, Myung-Deok, Kim, Sung-Soo, Cha, Hyun-Young, Jang, Seung-Hun, Chang, Da-Young, Kim, Wookhwan, Suh-Kim, Haeyoung, Lee, Jae-Ho |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4150933/ https://www.ncbi.nlm.nih.gov/pubmed/25145391 http://dx.doi.org/10.1038/emm.2014.49 |
Ejemplares similares
-
Effects of Adenoviral Gene Transduction on the Stemness of Human Bone Marrow Mesenchymal Stem Cells
por: Marasini, Subash, et al.
Publicado: (2017) -
In vivo priming of human mesenchymal stem cells with hepatocyte growth factor–engineered mesenchymal stem cells promotes therapeutic potential for cardiac repair
por: Park, Bong-Woo, et al.
Publicado: (2020) -
RAR‐Related Orphan Receptor Gamma (ROR‐γ) Mediates Epithelial‐Mesenchymal Transition Of Hepatocytes During Hepatic Fibrosis
por: Kim, Sung Min, et al.
Publicado: (2017) -
Neurogenin-1 Overexpression Increases the Therapeutic Effects of Mesenchymal Stem Cells through Enhanced Engraftment in an Ischemic Rat Brain
por: Kim, Gyu-Hee, et al.
Publicado: (2019) -
Hepatocyte Growth Factor/c-Met Signaling in Regulating Urokinase Plasminogen Activator in Human Stomach Cancer: A Potential Therapeutic Target for Human Stomach Cancer
por: Lee, Kyung Hee, et al.
Publicado: (2006)